Despite the FTC's aggressive stance and robust antitrust agenda, companies continue to pursue significant mergers, challenging current antitrust policies. Criticisms of the FTC's effectiveness and calls for legislative reform underscore the complexity of modern antitrust challenges. This narrative holds significant implications for the eDiscovery ecosystem, especially in antitrust investigations, underlining the importance of staying abreast of regulatory changes for eDiscovery professionals.

The post Pharmaceutical Industry Prepares for Regulatory Shift as FTC Shifts Antitrust Tactics appeared first on ComplexDiscovery.